Skip to content

A Study Comparing a New Widefield Fundus Camera with a Standard Camera for Detecting Retinal Conditions in Patients at an Eye Clinic.

Comparison of the Pristine 5.0 Widefield Fundus Camera with a Reference Standard Fundus Camera in a Retina Clinic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090725
Enrollment
218
Registered
2025-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H36- Retinal disorders in diseases classified elsewhere

Interventions

Intervention1: New widefield fundus camera: Retinal imaging performed using the new widefield fundus camera (model: Pristine 5.0) Intervention2: Nil: Nil Control Intervention1: Reference standard fund

Sponsors

Remidio Innovative Solutions Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Every consecutive participant above 18 years of age who consents to participate in the study and visit the retina clinic

Exclusion criteria

Exclusion criteria: Subjects with significant media opacity that blocks a sufficient view of the fundus, such as advanced cataracts, corneal opacity, vitreous hemorrhage, or other pathology. Subjects with inability to fixate on the target, such as those with nystagmus or amblyopia. Subjects with active eye infection, sudden loss of vision, or who are in the immediate post-operative period (less than two weeks). Subjects who are hypersensitive to light or unable to tolerate fundus imaging. Subjects for whom dilation is contraindicated, such as those with angle closure glaucoma or ocular hypertension.

Design outcomes

Primary

MeasureTime frame
Percentage of agreement between Diabetic Retinopathy (DR) stages detected using Pristine 5.0 and Reference Standard.Timepoint: Percentage of agreement between Diabetic Retinopathy (DR) stages detected using Pristine 5.0 and Reference Standard.

Secondary

MeasureTime frame
Assessment of image quality, including factors such as illumination, focus, fixation, and presence of external artifacts, for images captured using Pristine 5.0 and the Reference Standard.Timepoint: At the time of imaging (baseline visit);Sensitivity, specificity, positive predictive value, and negative predictive value of diabetic retinopathy detection by the Pristine 5.0 system compared to the Reference Standard.Timepoint: At the time of image interpretation (within 1 week of image capture);Sensitivity, specificity, positive predictive value, and negative predictive value of diabetic retinopathy diagnosis by the Pristine 5.0 system and the Reference Standard compared to the ophthalmologist diagnosis.Timepoint: At the time of image interpretation (within 1 week of image capture)

Countries

India

Contacts

Public ContactRanjitha K

Remidio Innovative Solution Pvt Ltd, Bengaluru, India

shonraj.b@remidio.com8886738267

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026